朗慧LangHui AIGet a proposal
Data Assets / Pharmaceuticals
Pharmaceuticals · Development direction

Clinical Drug Utilization Dataset

Real-world medication records, prescription analyses, medication frequency and treatment-course data.

Availability & project engagement

Data source & delivery

Development direction: data governance, annotation, and delivery design are planned around project requirements. Actual scope, provenance, quality, and delivery are subject to project authorization, compliance review, and written agreement.

Quality & governance

Project-defined quality protocol, versioned delivery, and scope confirmation.

Version & updated

2026.08 · 2026-08-22

Research & use boundary

This information describes data governance, medical annotation, research, and model-development scenarios. It does not constitute a diagnosis, treatment, efficacy, risk-prediction, or medical-device performance claim.

View asset profile

Real-world medication records, prescription analyses, medication frequency and treatment-course data.

Development direction: data governance, annotation, and delivery design are planned around project requirements. Actual scope, provenance, quality, and delivery are subject to project authorization, compliance review, and written agreement.

This information describes data governance, medical annotation, research, and model-development scenarios. It does not constitute a diagnosis, treatment, efficacy, risk-prediction, or medical-device performance claim.

Related assets

Reference

View Chinese reference page